Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction

---
identifier: "/us/fr/2022-00852"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2022-00852"
section_name: "Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction"
positive_law: false
currency: "2022-01-22"
last_updated: "2022-01-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF JUSTICE"
document_number: "2022-00852"
document_type: "notice"
publication_date: "2022-01-22"
agencies:
  - "DEPARTMENT OF JUSTICE"
  - "Drug Enforcement Administration"
---


#  Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction

**AGENCY:**

Drug Enforcement Administration, Justice.

**ACTION:**

Notice of application; correction.

**SUMMARY:**

The Drug Enforcement Administration (DEA) published a document in the *Federal Register* on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205—Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.

**SUPPLEMENTARY INFORMATION:**

**Correction**

In the *Federal Register* of August 12, 2021, in FR Doc. 2021-17181 (86 FR 44405), on page 44406, in the first column, in the controlled substance table, correct the drug schedule to schedule II.

Brian S. Besser,

Acting Assistant Administrator.